Andrews C, Shah K V, Rubin R, Hirsch M
J Infect Dis. 1982 Feb;145(2):276. doi: 10.1093/infdis/145.2.276.
Infections due to BK papovavirus frequently occur in renal transplant recipients [2] and may be involved in a variety of syndromes, including ureteral obstruction, deterioration of graft function, and pancreatic disease. The source of the BK papovavirus in these cases is not clear. Because the renal allograft has been implicated as a source of primary cytomegalovirus infections in renal transplant recipients [3], we investigated the possibility that donor kidneys may also contribute to the transmission of BK papovavirus. A fourfold or greater increase in titers of HAI antibodies to BK papovavirus was observed in 55 (24%) of 230 renal transplant recipients. Seronegative recipients who received kidneys from seropositive donors were 3.5 times more likely to develop an infection due to BK papovavirus than were seronegative recipients of kidneys from seronegative donors. The antibody status of the donor did not affect the likelihood of an increase in titers of antibody to BK papovavirus in seropositive recipients. These results suggest that BK papovavirus may be transmitted with transplanted kidneys and that transplant recipients who are at risk for primary infection by this route are more than twice as likely to have increased titers of antibody to BK papovavirus as those who are at risk for the reactivation of an infection. Further studies should be performed to define the relative role of cadaver vs. living, related kidney donors in the transmission of BK papovavirus and the clinical syndromes that are related to primary and reactivated infections.
BK多瘤病毒感染在肾移植受者中经常发生[2],可能与多种综合征有关,包括输尿管梗阻、移植肾功能恶化和胰腺疾病。这些病例中BK多瘤病毒的来源尚不清楚。由于肾移植受者的原发性巨细胞病毒感染被认为与肾移植有关[3],我们研究了供肾是否也可能传播BK多瘤病毒。在230名肾移植受者中,有55名(24%)观察到针对BK多瘤病毒的血凝抑制(HAI)抗体滴度升高了四倍或更多。接受血清阳性供者肾脏的血清阴性受者感染BK多瘤病毒的可能性是接受血清阴性供者肾脏的血清阴性受者的3.5倍。供者的抗体状态不影响血清阳性受者中BK多瘤病毒抗体滴度升高的可能性。这些结果表明,BK多瘤病毒可能通过移植肾传播,通过这种途径有原发性感染风险的移植受者抗体滴度升高的可能性是有感染再激活风险者的两倍多。应进行进一步研究以确定尸体供肾与活体亲属供肾在BK多瘤病毒传播中的相对作用以及与原发性和再激活感染相关的临床综合征。